Temazepam (Euhypnos) as a hypnotic: a multicentre trial in general practice

Area of Science:

• Pharmacology
• General Practice Medicine

Background:

• Insomnia is a common condition requiring effective and well-tolerated hypnotic medications.
• General practice settings necessitate practical and safe treatment options for sleep disorders.

Purpose of the Study:

• To evaluate the efficacy and tolerability of temazepam (Euhypnos) soft gelatine capsules as a hypnotic agent.
• To assess patient satisfaction and comparison with previous hypnotic treatments in a general practice setting.

Main Methods:

• A one-week study involving 236 patients in a general practice setting.
• Administration of soft gelatine capsules containing 10 mg temazepam (Euhypnos) with doses ranging from 10-30 mg.
• Evaluation of tolerability, patient satisfaction, hangover effects, and comparison with prior hypnotic medications.

Main Results:

• Temazepam (Euhypnos) doses of 10-30 mg were generally well tolerated by patients.
• Satisfactory performance was reported by 76% of the patients.
• Seventy-two percent of patients experienced no hangover effect, and 72% rated Euhypnos as effective as or superior to their previous hypnotics.

Conclusions:

• Temazepam (Euhypnos) soft gelatine capsules are a well-tolerated and effective hypnotic option in general practice.
• The medication demonstrates a favorable side effect profile, particularly regarding hangover effects.
• Patient-reported outcomes suggest high satisfaction and comparable or improved efficacy versus prior treatments.